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Endocrine pancreas 
reminder: how does endocrine pancreas work  
https://www.youtube.com/watch?v=kIPYVV4aThM 
http://philschatz.com/anatomy-book/resources/1820_The_Pancreas.jpg 
Endocrine pancreas 
reminder: the primary functions  
Production of pancreatic hormones 
by three cell types: Glucagon by 
alpha cells; Insulin by beta cells; 
Somatostatin by delta cells 
Hormones travel through the 
bloodstream to target tissues   
At the target cells, hormones bind 
specific receptors and cause cell 
changes that control metabolism 
 http://www.daviddarling.info/images/islets_of_Langerhans.gif 
http://www.easynotecards.com/uploads/492/72/_5abec72a_142b10a4854__8000_00002085.PNG 
Endocrine pancreas 
reminder: insulin & glucagon in glucose metabolism regulation 
 
http://www.bio.davidson.edu/Courses/Molbio/MolStudents/spring2003/Williford/structure_insulin.gif 
Endocrine pancreas 
reminder: structure & roles of insulin 1 
 
• Insulin is a polypeptide hormone, composed of two 
chains (A and B) 
• Both chains are derived from proinsulin 
(prohormone) 
• Chains are joined by disulfide bonds 
 
http://www.bio.davidson.edu/Courses/Molbio/MolStudents/spring2003/Williford/structure_insulin.gif 
Endocrine pancreas 
reminder: structure & roles of insulin 2 
 
• Acts on tissues to increase uptake of glucose and 
amino acids 
• Increases glycogen production (glucose storage) in 
the liver and muscle 
• Stimulates lipid synthesis from free fatty acids and 
triglycerides in adipose tissue 
• Also stimulates potassium uptake by cells (role in 
potassium homeostasis)  
 
http://www.easynotecards.com/uploads/492/72/_5abec72a_142b10a4854__8000_00002085.PNG 
Endocrine pancreas 
reminder: insulin secretion control’ mechanisms 1 
 
• Chemically – high levels of glucose and amino acids 
in the blood 
• Hormonally – beta cells are sensitive to several 
hormones that may inhibit or cause insulin 
secretion 
• Neurally – stimulation of the parasympathetic 
nervous system causes insulin to be secreted 
 
http://www.easynotecards.com/uploads/492/72/_5abec72a_142b10a4854__8000_00002085.PNG 
Endocrine pancreas 
reminder: insulin secretion control’ mechanisms 2 
 
• Insulin secretion is decreased by decreased glucose 
and increased insulin concentration in blood and 
sympathetic stimulation 
• Insulin transported through the blood to target 
tissues where it binds to target cells’ specific 
receptors and acts as a biochemical signal to the 
inside of the cell: cell metabolism is stimulated  
 
 
http://www.heartlandscf.org/assets/images/shutterstock_76973791glucose%20monitor.jpg 
Endocrine pancreas 
reminder: blood fasting glucose levels 
• The normal range - a narrow range of 
about 3.9 to 5.5 mmol/L  (as measured by 
a fasting blood glucose test) 
• Hyperglycemia -  high levels  
– Short term (physiological, pathological) 
–Persistent  
• impaired – pre-diabetes 
• high -  esp. diabetes mellitus  (DM) 
• Hypoglycemia   - low levels   
Endocrine pancreas 
reminder: purpose 
• General evaluation of health 
• Diagnosis of disease or disorders of endocrine 
pancreas 
• Diagnosis of other systemic diseases that affect 
endocrine pancreas 
http://doctormurray.com/wp-content/uploads/2013/10/type-2-diabetes.jpg 
Endocrine pancreas 
 history-taking: patient’s interviewing    
 gathering of information 
 patient’s narrative 
 biomedical perspective 
 psychosocial perspective 
 context 
http:// http://www.accurateinsulin.org/wp-content/uploads/2013/06/doctor-patient.jpg 
Endocrine pancreas 
clinical monitoring diabetic complications 
http://www.questdiagnostics.com/testcenter/testguide.action?dc=TG_Diabetes 
Clinical Tests 
Blood pressure Management; monitor hypertension 
and thus risk of heart disease 
Eye exam Management; monitor onset and 
progression of eye disease 
Foot exam Management; monitor onset and 
progression of nerve disease and 
peripheral arterial disease 
The American Diabetes Association (ADA) 
recommendations: 
• Obesity (BMI >25 kg/m2) – consider testing to 
detect pre-DM and type 2 DM in asymptomatic 
people 
• Family history of  DM in first- or second-degree 
relative  
Endocrine pancreas 
patient's laboratory examination:  indications for testing 1 
 
http://www.anylabtestnow.com/tests/diabetes-maintenance-panel/ 
The American Diabetes Association (ADA) 
recommendations: 
• Signs of insulin resistance or conditions associated 
with insulin resistance (e.g., acanthosis nigricans, 
hypertension, dyslipidemia, low birthweight) 
• Maternal history of DM or gestational diabetes 
mellitus (GDM) during gestation 
Endocrine pancreas 
patient's laboratory examination:  indications for testing 2 
 
http://www.anylabtestnow.com/tests/diabetes-maintenance-panel/ 
  
• Complete Blood Count (CBC) 
• Glucose, Serum (Fasting) 
• Oral glucose tolerance test (OGTT) 
• Random blood glucose 
• Islet cell antibody test (for type 1 diabetes) 
• Hemoglobin A1c (glycated haemoglobin) 
• Diabetic Urinalysis 
 
 
Endocrine pancreas 
patient's laboratory examination:  diabetes  panel 1 
http://www.anylabtestnow.com/tests/diabetes-maintenance-panel/ 
The current WHO diagnostic criteria for diabetes should 
be maintained  
– fasting plasma glucose ≥ 7.0mmol/l (126mg/dl) or 2–h 
plasma glucose ≥ 11.1mmol/l (200mg/dl  
– HbA1c ≥ 6.5% = diabetes mellitus, HbA1c 5.7 to 6.4% = 
pre-diabetes or at risk of diabetes  
Glycated haemoglobin  - HbA1c - reflects average plasma 
glucose over the previous 2–3 months in a single measure 
which can be performed at any time of the day and does 
not require any special preparation such as fasting  
Endocrine pancreas 
patient's laboratory examination:  diabetes  panel 2 
Endocrine pancreas 
patient's laboratory examination:  diagnostic significance of glucose 
and glycated haemoglobin concentrations 
http://www.anylabtestnow.com/tests/diabetes-maintenance-panel/ 
Individuals Suitable  
for Testing 
Marker 
Clinically 
Significant  
Level 
Interpretation 
Non-pregnant individuals 
with diabetes risk factors 
or age ≥45 years and pregnant 
women with risk factors (first 
prenatal visit) 
FPG 
2-h OGTT (75 g) 
HbA1c   
≥126 mg/dL 
≥200 mg/dL 
≥6.5% 
Diabetes 
FPG 
2-h OGTT (75 g) 
HbA1c   
100-125 mg/dL 
140-199 mg/dL 
5.7%-6.4% 
Increased risk 
for 
diabetes 
All pregnant women  
(24-28 weeks of gestation) 
2-h OGTT (75 g) 
•Fasting 
•1 h 
•2 h 
≥92 mg/dL 
≥180 mg/dL 
≥153 mg/dL 
Gestational 
diabetes 
  
FPG, fasting plasma glucose; OGTT, oral glucose tolerance test; HbA1c, 
hemoglobin A1c. 
 
• Glucosuria can be detected 
when level of blood glucose 
exceeds more than 11 mmol/l 
• Urine tests can’t be used to 
alone to confirm the diagnosis 
of diabetes mellitus 
• They are ordered more often 
when there is suspicition on 
type 1 diabetes 
• Laboratories can test urine for 
ketone bodies  
Endocrine pancreas 
patient's laboratory examination:  diabetic urinalysis 1 
 
 
http://www.biosynergypro.com/uploads/1/2/9/0/12905439/_8435009_orig.png 
• The body produces ketone 
bodies when fat tissue is used 
for energy instead of blood 
sugar 
• If ketone bodies are present in 
the urine, this could indicate the 
high level of glucose in blood 
with insufficient level of insulin 
production 
Endocrine pancreas 
patient's laboratory examination:  diabetic urinalysis 2 
 
 
http://www.biosynergypro.com/uploads/1/2/9/0/12905439/_8435009_orig.png 
http://diabetespharmacist.wp.lexblogs.com/wp-content/uploads/sites/346/2013/09/Blood-glucose-monitors.jpg 
https://upload.wikimedia.org/wikipedia/commons/6/62/Blausen_0301_Diabetes_GlucoseMonitoring.png 
Implantable 
Endocrine pancreas 
Glucose Meters 
Continuous glucose monitors 
(CGMs)contain subcutaneous 
sensors that measure 
interstitial glucose levels 
every 1-5 minutes, providing 
alarms when glucose levels 
are too high or too low or are 
rapidly rising or falling  
 
https://www.medtronicdiabetes.ca/sites/canada/www.medtronicdiabetes.ca/files/styles/245px_list_image/public/veoml-on-body_1.jpg?itok=CIC_4ZHY 
http://blog.amal.net/wp-content/uploads/2010/02/glucose_monitoring.jpg http://emedicine.medscape.com/article/117739-overview#showall 
Implantable 
Endocrine pancreas 
Continuous Glucose Monitors (CGMs) 
Endocrine pancreas 
high level persistent hyperglycemia (DM): types 1   
• DM type 1 results from the body's failure to 
produce enough insulin 
• Main risk factors: viruses and toxins that can 
affect genetically determinated antigens of HLA 
system and cause autoimmune destruction of 
beta cells in the islets of Langerhans   
Endocrine pancreas 
high level persistent hyperglycemia (DM): types 2   
• DM type 2 begins with insulin resistance, a 
condition in which cells fail to respond to insulin 
properly 
• As the disease progresses a lack of insulin may 
also develop 
• This form was previously referred to as "non 
insulin-dependent diabetes mellitus" (NIDDM) or 
"adult-onset diabetes“ 
• The primary cause is excessive body weight and 
lack of exercise   
Endocrine pancreas 
high level persistent hyperglycemia (DM): types 3   
• Gestational diabetes, is the third main form and 
occurs when pregnant women without a previous 
history of diabetes develop a high blood glucose 
level  
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
classic & other clinical symptoms 1 
 
Classic   
• Polyphagia (increased hunger) 
• Polyuria (frequent urination) 
• Polydipsia (increased thirst) 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
classic & other clinical symptoms 2 
 
Other   
• Blurred vision 
• Fatigue 
• Weight loss 
• Poor wound healing (cuts, scrapes, etc.) 
• Dry mouth 
• Dry or itchy skin  
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
early & later clinical symptoms 3 
 
Other   
• Impotence (male) 
• Recurrent infections such as vaginal yeast 
infections, groin rash, or external ear infections 
(swimmers ear) 
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
early & later clinical symptoms 1 
 
Early   
• Frequent urination 
• Increased thirst 
• Blurred vision 
• Fatigue 
• Headache 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
early & later clinical symptoms 2 
 
Later (ketoacidosis) 
• Fruity-smelling breath 
• Nausea and vomiting 
• Shortness of breath 
• Dry mouth 
• Weakness 
• Confusion, Coma 
• Abdominal pain 
https://thumbs.dreamstime.com/z/diabetes-mellitus-diabetic-signs-symptoms-clipart-illustrations-showing-disease-such-as-weight-loss-extreme-tiredness-61592413.jpg 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
early & later clinical symptoms 3 
http://www.soccerpluseducation.org/images/treatment-for-type-i-and-type-ii-diabetes-80009.jpg 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
early & later clinical symptoms 4 
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications: diabetic ketoacidosis 1 
 
 • A potentially life-threatening complication happens 
in pts DM 1, it can occur in those with DM 2  
• The symptoms usually evolve over the period of 
about 24 hours 
• Predominant symptoms are nausea and vomiting, 
pronounced thirst, excessive urine production, 
and abdominal pain 
•  Breathing becomes labored and of a deep, gasping 
character (Kussmaul respiration)  
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications: diabetic ketoacidosis 2 
 
• In severe cases there may be confusion, lethargy, 
stupor, coma   
• On physical examination there is evidence 
of dehydration (tachycardia,  low blood pressure), 
"ketotic" odor , and death 
• Blood analysis will reveal significant decreased pH  < 
7.30 mmol/l  
• Urine analysis will reveal significant levels of ketone 
bodies, often before other overt symptoms  
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications:  nonketotic hyperosmolar state 1 
 
 • An acute complication sharing many symptoms with 
diabetic ketoacidosis, but an entirely different origin   
• Water osmotically drawn out of cells into the blood  
• The kidneys eventually begin to dump glucose into 
the urine 
• Serum pH >7.30, bicarbonate >15 mEq/L, small 
ketonuria  and absent-to-low ketonemia 
(<3 mmol/L)  
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications:  nonketotic hyperosmolar state 2 
 
• Increased risk of blood clot formation 
• If fluid is not replaced, the osmotic effect of high 
glucose levels, combined with the loss of water, will 
eventually lead to dehydration 
• Some alteration in consciousness, lethargy may 
ultimately progress to a coma    
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications:  coma 1 
• A  life-threatening DM complication that causes 
unconsciousness 
• Three different types : 
– Severe low blood sugar in a DM person 
–Diabetic ketoacidosis advanced enough to result 
in unconsciousness from a combination of a 
severely increased blood sugar 
level, dehydration and shock, and exhaustion  
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications:  coma 2 
• Three different types : 
–Hyperosmolar nonketotic coma in which an 
extremely high blood sugar level 
and dehydration alone are sufficient to cause 
unconsciousness 
• Diabetic coma was a diagnostic problem before the 
late 1970s, when glucose meters and rapid blood 
chemistry analyzers became universally available in 
hospitals 
 
 
 
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications: hypoglycemia 1 
 
 
 
•  A medical emergency that involves an abnormally 
diminished content of glucose in the blood  
•  Symptoms hypoglycemia usually do not occur 
until  2.8 to 3.0 mmol/L  
• Adrenergic manifestations: shakiness, anxiety, 
nervousness, palpitations, tachycardia, sweating, 
pallor, coldness, clamminess, mydriasis  
 
 
Endocrine pancreas 
high level persistent hyperglycemia (DM)   
acute complications: hypoglycemia 2 
 
 
 
•  Glucagon manifestations: 
hunger, nausea, vomiting, abdominal discomfort, 
headache 
• Neuroglycopenic manifestations: abnormal 
thinking,  depression, crying, exaggerated concerns, 
paresthesia, negativism, emotional lability, fatigue, 
weakness, apathy, lethargy, daydreaming, 
confusion, amnesia, blurred vision, automatic 
behavior, difficulty speaking, incoordination, motor 
deficit, paresthesia, headache, stupor, coma, etc. 
 
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
chronic complications 1 
 
Microvascular   
• Diabetic cardiomyopathy   
• Diabetic nephropathy    
• Diabetic neuropathy      
• Diabetic retinopathy       
• Diabetic encephalopathy     
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
chronic complications 2 
 
Macrovascular  
• Coronary artery disease     
• Diabetic myonecrosis     
• Peripheral vascular disease     
• Stroke  
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
chronic complications 3 
 
Other 
• Gastrointestinal (gastroparesis, diarrhea) 
• Genitourinary (uropathy/sexual dysfunction) 
• Dermatologic 
• Infectious 
• Cataracts 
• Glaucoma 
• Periodontal disease  
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
main chronic complications 
 
http://www.idf.org/complications-diabetes http://care4feet.org.au/images/diabetic_foot.jpg  http://santamariamedicine.com/wp-
content/uploads/2014/04/graphic-heart-attack-story.jpg http://biomed.brown.edu/Courses/BI108/BI108_2008_Groups/group04/images/disease/kidney.png  
• Diabetic retinopathy results in 
scattered hemorrhages, yellow 
exudates, and neovascularization 
• This patient has neovascular 
vessels proliferating from the optic 
disc, requiring urgent panretinal 
laser photocoagulation 
 
Endocrine pancreas 
high level persistent hyperglycemia (DM):  
main chronic complications 
 
• Low blood sugar is common in patients with DM, 
but most cases are mild and are not considered 
medical emergencies 
• Effects can range from feelings of unease, 
sweating, trembling, and increased appetite in 
mild cases to more serious issues such 
as confusion, aggressiveness, seizures, 
unconsciousness, and (rarely) permanent brain 
damage or death in severe cases  
https://en.wikipedia.org/wiki/Diabetes_mellitus#Signs_and_symptoms 
 
Endocrine pancreas 
hypoglycemia (DM)  
 
http://www.healthline.com/hlcmsresource/images/diabetesmine/wp-content/uploads/2013/11/Low-Blood-Sugar-Symptoms.jpg 
 
Endocrine pancreas 
hypoglycemia (DM)  
 
